Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection
Laurie G. Jacobs(Hackensack Meridian Health), Judy L. Aschner(Wake Forest University), Nabiha Qureshi(Hackensack University Medical Center), Dineen Lesky-Di Bari(Hackensack University Medical Center), Marygrace Zetkulic(Hackensack University Medical Center), Tamara Friedman(Hackensack Meridian Health), Lily Rasouli(Hackensack University Medical Center), Elli Gourna Paleoudis(Hackensack Meridian Health), Lauren Berrol(Hackensack University Medical Center), Anjali Gupta(Duke University), Harinder Singh Bawa(Hackensack University Medical Center), Themba Nyirenda(Hackensack University Medical Center), Chinwe Ogedegbe(Center for Discovery), Bindu Balani(Association Clinique et Thérapeutique Infantile du Val de Marne)
Cited by 334
Related Papers
Inhaled Nitric Oxide for Premature Infants with Severe Respiratory Failure
|New England Journal of Medicine|2005|306
The Environmental Influences on Child Health Outcomes (ECHO)-Wide Cohort
|American Journal of Epidemiology|2023|184
Remdesivir for Severe Coronavirus Disease 2019 (COVID-19) Versus a Cohort Receiving Standard of Care
|Clinical Infectious Diseases|2020|171
Parkinson Disease Affects Peripheral Sensory Nerves in the Pharynx
|Journal of Neuropathology & Experimental Neurology|2013|155